Ethylene glycol (chemical formula C₂H₆O₂, CAS number 107-21-1) is a colourless, odourless, and syrupy liquid known for its distinctly sweet taste. It can also exist in the air as a vapour. Commonly referred to as “glycol” or “glycol alcohol,” ethylene glycol is a versatile compound widely used in both industrial and consumer applications.
Ethylene glycol is primarily used as a raw material in the production of antifreeze and de-icing solutions for vehicles, aircraft, boats, and runways. Its utility extends well beyond this: it’s used in cooling and heating systems, hydraulic brake fluids, electrolytic condensers, and plasticisers.
It also plays a role in the manufacture of polyethylene terephthalate (PET) bottles, lacquers, resins, wood stains, dyes for leather, and photographic developing solutions. In the textile industry, it aids in processing and helps create polyester fibres and synthetic waxes.
Additionally, it’s found in cosmetics, pharmaceuticals, and certain food-contact applications. Ethylene glycol is also used to produce artificial smoke or mist for theatrical productions and is a key component in various printing inks and extinguishing foams.
Occupational exposure to ethylene glycol may occur through inhalation or skin contact during its production or use. It may enter the environment through industrial wastewater, de-icing operations, spills, or improper disposal of antifreeze and solvents.
The most common exposure routes include:
Once ingested, ethylene glycol is rapidly and extensively absorbed via the gastrointestinal tract. Absorption through the skin is slower, and there is limited data on respiratory uptake.
After absorption, it distributes throughout the body and undergoes a series of metabolic transformations. These processes yield various metabolites, including glycine, malate, oxalic acid, formate, and carbon dioxide.
Ethylene glycol is eliminated from the body through two main routes:
Its elimination half-life ranges between 2.5 to 8.4 hours, and higher doses can lead to a saturated metabolic pathway, increasing excretion via urine.
Large ingestions of ethylene glycol can result in three distinct stages of toxicity:
In animal models (rats, mice, rabbits, guinea pigs), ethylene glycol has shown moderate acute toxicity via inhalation or dermal exposure and low to moderate toxicity through ingestion.
Long-term inhalation exposure to low concentrations may cause irritation of the throat and upper respiratory tract. Chronic dietary exposure in rats has resulted in kidney and liver toxicity. Subchronic inhalation exposure in animals has caused ocular damage, lung inflammation, and other organ effects.
The US EPA has set an oral reference dose (RfD) of 2.0 mg/kg/day, based on kidney toxicity observed in rats. No reference concentration (RfC) has been established for inhalation.
There is no definitive data on reproductive or developmental impacts in humans. However, animal studies have shown ethylene glycol can cause:
It’s important to note that in some inhalation studies, animals ingested ethylene glycol through grooming, complicating the interpretation of results.
Epidemiological studies have not shown an increased risk of cancer (e.g., renal cancer) in workers exposed to ethylene glycol. Similarly, animal studies conducted by the National Toxicology Programme (NTP) found no significant increase in tumour incidence.
As a result, the US EPA has not classified ethylene glycol as carcinogenic.
Eye Contact
Skin Contact
Inhalation
Ingestion
Note: Individuals with pre-existing kidney, respiratory, neurological, or eye conditions may be more sensitive to ethylene glycol exposure.
Eyes:
Skin and Body:
Respiratory Protection:
Important: Always consult a safety specialist prior to handling ethylene glycol in hazardous scenarios to ensure PPE adequacy.